Novo Nordisk's Wegovy debuts in India: How it works, who it's for, and how much it costs
Source: iStock
In a major development for India's fast-growing anti-obesity drug market, Novo Nordisk on Tuesday officially launched Wegovy, its highly anticipated weight-loss medication, marking a direct challenge to Eli Lilly's already available Mounjaro.
Wegovy will be rolled out as a once-weekly injectable, delivered via a FlexTouch pen-like device—a user-friendly, self-administered format that eliminates the need for vials or syringes. The drug is expected to be available in Indian pharmacies by the end of June 2025, according to Vikrant Shrotriya, Managing Director of Novo Nordisk India.
A market ripe for disruption
Novo Nordisk is betting big on India, where nearly 254 million people live with generalized obesity and 351 million with abdominal obesity.
The Danish pharma giant sees India as a key market for future sales, aiming to capture a large share of the country's ₹576 crore anti-obesity drug market, which has quadrupled from ₹133 crore in 2021, according to PharmaTrac.
'Obesity is not just a personal health concern — it is a chronic disease and a national epidemic that India cannot afford to ignore,' said Shrotriya. 'We are bringing Wegovy with the convenience of a world-class, state-of-the-art pen device, and an India-specific price.'
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
5 Books Warren Buffett Wants You to Read In 2025
Blinkist: Warren Buffett's Reading List
Undo
Source: iStock
How Wegovy works: Science behind the shot
Wegovy contains semaglutide, a GLP-1 receptor agonist, which mimics a natural hormone responsible for regulating blood sugar, reducing appetite, delaying gastric emptying, and improving satiety. While related drugs like Ozempic are used primarily for type 2 diabetes, Wegovy is specifically approved for chronic weight management in cases of morbid obesity.
The FlexTouch device allows patients to dial in their weekly dose, with four needles included in each monthly pack.
The drug works on key centers of the brain that regulate hunger and food cravings, promoting weight loss while offering additional metabolic benefits.
According to diabetologist Dr. V. Mohan, 'Clinical data on semaglutide demonstrates not just weight loss but also considerable improvement in cardiovascular risk factors and inflammatory markers. For Indians, where diabetes and heart disease are on the rise, access to such evidence-based therapy offers holistic benefits.'
India-specific pricing for Wegovy: Full dose list
With a pricing strategy tailored for the Indian market, Novo Nordisk is offering the same cost for the initial three dosing strengths:
Dose
Monthly Price (₹)
Per Dose (₹)
0.25 mg
₹17,345
₹4,366
0.5 mg
₹17,345
₹4,366
1 mg
₹17,345
₹4,366
1.75 mg
₹24,280
₹6,070
2.4 mg
₹26,015
₹6,503
By comparison, Mounjaro, which contains the dual-action compound tirzepatide, is priced more competitively:
Source: iStock
Mounjaro Dose
Monthly Price (₹)
2.5 mg
₹14,000
5 mg
₹17,500
Results comparable to bariatric surgery — but with caveats
Wegovy has demonstrated remarkable outcomes in clinical studies, positioning it as a breakthrough in the treatment of obesity and related conditions. Patients using the drug experienced an average weight loss of nearly 15%, with one in three shedding as much as 20% of their body weight. Beyond weight loss, Wegovy also significantly
reduces
the risk of major cardiovascular events such as heart attacks and strokes.
The drug also had notable benefits for liver health and showed improvement in liver fibrosis. However, the benefits of Wegovy are tied closely to continued use. Discontinuation often results in weight regain, and medical experts have raised concerns about potential muscle mass loss over time, underscoring the need for long-term management and monitoring.
Wegovy vs. Mounjaro: Key differences
Aspect
Wegovy (Semaglutide)
Mounjaro (Tirzepatide)
Mechanism
GLP-1 receptor agonist
Dual GIP and GLP-1 receptor agonist
Effect
Reduces appetite, delays gastric emptying
Enhances insulin secretion, appetite suppression
Indication
Approved for weight loss
Approved for diabetes, used off-label for weight loss
Dosing
Once a week via Flexpen
Once a week via single-dose vials
Price
₹17,345–₹26,015 per month
₹14,000–₹17,500 per month
One step to a healthier you—join Times Health+ Yoga and feel the change
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
19 minutes ago
- Indian Express
My patient's blood sugar level was going up after meals despite a balanced thali: What did he miss?
One of my patients was troubled by his post-meal readings. 'I now eat on time, have a healthy thali of home-cooked food — sabzi (vegetables), dal, salad, a small portion of rice or roti. But my post-meal reading came to 210 mg/dL, when it should not be more than 140 mg/dL. The reading after two hours of eating a meal came to 280 mg/dL, which should be less than 180 mg/dL. What am I doing wrong?' he asked me. Despite a balanced Indian thali every day, he was still experiencing post-meal fatigue, sugar spikes or cravings. The issue was not what he was eating but how he was eating it. So we reversed the order of what he ate first. We made him have salads and vegetables first, both of which are fibre-rich. Then we followed it up with dal, soybean or protein, which added further heft to the meal. In the end we followed up a remnant of all these with rice or roti. By then he was quite full and had very little of the carbs. His blood sugar levels gradually went down to normal by simply shuffling his food around. Why food sequence matters Our bodies process different nutrients at different rates. When carbohydrates are eaten first, especially refined ones like white rice or breads, they quickly break down into sugar, causing a sharp rise in blood glucose. This can trigger insulin surges and a subsequent drop in energy. However, when fibre and protein are eaten first, they slow the digestion and absorption of sugars that follow. The Ideal Eating Order For better blood sugar regulation, follow this simple sequence. Fibre first: Begin your meal with a portion of salad, sautéed vegetables or lightly cooked greens. The soluble fibre in these foods helps form a gel-like barrier in the stomach, delaying the absorption of sugars from subsequent foods. Protein and healthy fats next: This includes dal, curd, paneer, tofu, eggs, or lean meat. Proteins and fats further slow gastric emptying and promote satiety, which can help reduce the total quantity of food consumed. Carbohydrates last: End your meal with rice, roti, or other grains. Eating carbs at the end allows your body to digest them more slowly, leading to a lower glucose response post-meal. A Note on Dal: Protein or Carb? Dal is often celebrated for being rich in plant-based protein. However, it's important to note that dals also contain a significant amount of carbohydrates. While they are a nutrient-dense option, their carb content should be accounted for in the total calories allowed per day — especially when paired with other carbohydrate-rich foods like rice or chapati. Researchers in Japan tested participants with the same meal, which consisted of protein, vegetables and white rice. When participants began by eating a simple carbohydrate — in this case, white rice — their post-meal blood glucose and insulin levels were measurably higher than those who had eaten the white rice last. Conversely, when those same participants began by eating protein and vegetables and saved the rice for last, their post-meal insulin and glucose levels were measurably lower. Include probiotic-rich foods like yoghurt or buttermilk. Probiotics can help improve gut health and potentially reduce blood sugar spikes. (Dr Bhattacharya is endocrinologist, Indraprastha Apollo Hospitals, New Delhi)
Time of India
an hour ago
- Time of India
Game-changer HIV shot approved in US may enter Canada by 2026; Just two injections a year
A twice-a-year injectable drug being hailed as a breakthrough in HIV prevention could be available in Canada as early as mid-2026, offering new hope in the fight against the virus. The drug, lenacapavir , developed by Gilead Sciences , was approved by the US Food and Drug Administration (FDA) last week for pre-exposure prophylaxis (PrEP). It is the first and only HIV prevention medication that requires just two doses per year. Gilead Canada submitted the drug to Health Canada in April for review, which was accepted earlier this month. Lenacapavir was approved in Canada in 2022 for treatment, but this is the first time it's under review for prevention. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Free P2,000 GCash eGift UnionBank Credit Card Apply Now Undo 'This is absolutely a monumental advance in prevention,' said Peter Newman, a professor at the University of Toronto whose work focuses on HIV prevention. 'It's certainly cost-effective in the long run because you're going to prevent a lot of cases of new HIV.' How does it work Live Events Lenacapavir works by creating a slow-release 'depot' of medicine under the skin, delivering protection for six months. Clinical trials showed near-total effectiveness: among more than 2,000 high-risk women in Africa, zero new infections were recorded. In another trial among gay and bisexual men and transgender women, only two infections occurred, both in participants who were already HIV-positive before the injection. Very expensive Gilead's US list price is $28,218 a year, sparking concerns about access and affordability, especially for marginalized groups. 'We could get a lot of interest, but if people can't afford it, it's dead in the water,' O'Byrne said. Currently in Canada, 54 percent of PrEP prescriptions are paid for by private insurance and 43 percent by public programs, according to the Public Health Agency of Canada. Gilead says it will work with both public and private payers to 'accelerate availability and access.' If approved, the shot will only be available through healthcare providers, doctors, or nurses. But experts argue it should be expanded to include pharmacists and nurse practitioners, especially to increase access in remote or underserved areas.
Time of India
2 hours ago
- Time of India
AI 171 crash: 260 deaths confirmed, verification still on: Gujarat health minister
1 2 Ahmedabad: Rushikesh Patel, the state health minister said that 260 people have been confirmed dead till Tuesday in the Air India 171 plane crash incident even as further verification process is ongoing. "Some verification work is still ongoing, but so far 260 deaths have been confirmed by DNA match and other methods along with police verification," said Patel. Govt sources said that it could take a couple of more days before the final casualty can be ascertained based on scientific evidence. Health department officials said that the 260 confirmed dead so far include 241 passengers and crew onboard the ill-fated flight and 19 confirmed deaths on ground due to impact and subsequent fireball where the temperature soared to about 1,000°C. Sources said that the actual figure of the deaths in the incident will only be confirmed after completion of the DNA match process. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad "Till Tuesday, 259 persons who died in the crash have been identified. These include 240 persons aboard the AI 171 along with 13 persons who died on the ground who were identified using DNA match. Six other persons who died on the ground were identified by their kin based on their physical and facial features," said Dr Rakesh Joshi, medical superintendent of the Civil Hospital, Ahmedabad which is coordinating the handing over of mortal remains of the plane crash victims to the relatives. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo Health department officials said that till Tuesday, DNA match for one of the 241 passengers remains to be ascertained. Sources said a few samples continue to remain with the Gandhinagar-based forensic laboratories in highly charred condition. "Forensic experts are attempting to extract the DNA using advanced methods," said a source. Meanwhile, Civil Hospital authorities handed over mortal remains of a UK resident on Tuesday, taking the number of handed-over bodies from the crash to 257. Dr Joshi said that two bodies remain with the authorities and both are UK nationals. "They are likely to be sent home soon for the last rites," he said. All 60 passengers with foreign nationalities including 52 from the UK, seven from Portugal, and one from Canada have been identified and 58 of them have been sent home, said officials. Among the Indian nationals, the highest death toll is recorded for Ahmedabad at 73. Noel Tata visits crash site, patients in Ahmedabad Ahmedabad: Tata Trusts chairman Noel Tata made a brief visit to Ahmedabad on Tuesday in the aftermath of the Air India 171 plane crash on June 12. Tata is reported to have visited the airplane crash site in Meghaninagar, patients admitted at the Civil Hospital, and city police commissioner GS Mallik. Confirming Tata's visit, Mallik said that it was a courtesy call following the plane crash tragedy. "He thanked the city police for their work following the crash and appreciated our commitment," said Mallik, adding it was an informal visit. Sources at the airport said that Tata arrived at the General Aviation terminal of Sardar Vallabhbhai Patel International Airport (SVPI) around 7am and departed by 2pm the same day, via chartered aircraft. Officials at Civil Hospital confirmed that a Tata-group delegation visited the hospital on Tuesday. "The delegation discussed the crash incident, the hospital's response to the incident and the health of injured victims," a senior official of the hospital said. BJMC fraternity pays homage to deceased students Ahmedabad: On Tuesday, 12 days after the devastating air crash on the mess of the BJ Medical College, the BJ Medical College fraternity paid homage to the four medical students and other victims of the AI 171 airplane crash. The prayer meet was attended by state health minister Rushikesh Patel, along with senior health department officials, Civil Hospital staff, students and tutors, and relatives of the deceased. The senior officials also planted trees on the medical college campus as a remembrance of the deceased students. About 25 persons, several of them medical students, were also injured in the crash. The majority of them have recuperated and joined duty, said officials.
